SLFN5 as a dual-function oncogene and immune regulator: A pan-cancer multi-omics analysis linking prognosis, immune evasion, and therapeutic vulnerability
- DOI
- 10.1016/j.ctarc.2026.101145
- Published
- 2026
- Container
- Cancer Treatment and Research Communications
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctarc.2026.101145,
title = {SLFN5 as a dual-function oncogene and immune regulator: A pan-cancer multi-omics analysis linking prognosis, immune evasion, and therapeutic vulnerability},
author = {Fubiao Kang and Ziye Yang and Dong Li and Delong Lv and Peihua Su and Yan Wang and Lianli Zhang},
year = {2026},
journal = {Cancer Treatment and Research Communications},
doi = {10.1016/j.ctarc.2026.101145},
url = {https://doi.org/10.1016/j.ctarc.2026.101145}
}RIS
TY - JOUR TI - SLFN5 as a dual-function oncogene and immune regulator: A pan-cancer multi-omics analysis linking prognosis, immune evasion, and therapeutic vulnerability AU - Fubiao Kang AU - Ziye Yang AU - Dong Li AU - Delong Lv AU - Peihua Su AU - Yan Wang AU - Lianli Zhang PY - 2026 JO - Cancer Treatment and Research Communications DO - 10.1016/j.ctarc.2026.101145 UR - https://doi.org/10.1016/j.ctarc.2026.101145 ER -
APA
Kang, F., Yang, Z., Li, D., Lv, D., Su, P., Wang, Y., & Zhang, L. (2026). SLFN5 as a dual-function oncogene and immune regulator: A pan-cancer multi-omics analysis linking prognosis, immune evasion, and therapeutic vulnerability. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101145
Source records
- crossref · retrieved 2026-09-27T16:47:04.593Z